Evolutionary Tree Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,881
| Closed | -$2.54M | – | 32 |
|
|
2024
Q4 | $2.54M | Sell |
20,881
-2,118
| -9% | -$258K | 2.58% | 17 |
|
|
2024
Q3 | $2.87M | Buy |
22,999
+2,036
| +10% | +$254K | 2.88% | 16 |
|
|
2024
Q2 | $3.31M | Sell |
20,963
-5,065
| -19% | -$800K | 3.41% | 10 |
|
|
2024
Q1 | $3.37M | Buy |
26,028
+6,562
| +34% | +$850K | 3.39% | 8 |
|
|
2023
Q4 | $1.88M | Buy |
19,466
+2,816
| +17% | +$272K | 2.07% | 23 |
|
|
2023
Q3 | $2.02M | Sell |
16,650
-3,186
| -16% | -$386K | 2.6% | 16 |
|
|
2023
Q2 | $2.27M | Sell |
19,836
-16,354
| -45% | -$1.87M | 2.73% | 13 |
|
|
2023
Q1 | $4.99M | Sell |
36,190
-27,566
| -43% | -$3.8M | 6.91% | 5 |
|
|
2022
Q4 | $8.26M | Buy |
63,756
+3,525
| +6% | +$457K | 7.93% | 1 |
|
|
2022
Q3 | $6.66M | Buy |
60,231
+10,006
| +20% | +$1.11M | 6.4% | 3 |
|
|
2022
Q2 | $3.77M | Sell |
50,225
-9,074
| -15% | -$680K | 4.1% | 9 |
|
|
2022
Q1 | $4.63M | Sell |
59,299
-37,396
| -39% | -$2.92M | 3.22% | 11 |
|
|
2021
Q4 | $8.71M | Buy |
96,695
+9,482
| +11% | +$854K | 4.18% | 7 |
|
|
2021
Q3 | $8.07M | Buy |
87,213
+8,883
| +11% | +$821K | 3.58% | 8 |
|
|
2021
Q2 | $6.09M | Buy |
78,330
+9,393
| +14% | +$730K | 2.81% | 14 |
|
|
2021
Q1 | $5.14M | Buy |
68,937
+39,265
| +132% | +$2.93M | 3.04% | 14 |
|
|
2020
Q4 | $5.06M | Buy |
+29,672
| New | +$5.06M | 3.86% | 9 |
|